Smallpox vaccination and the real burden of adverse reactions
In January, implementation of the federal government's plan to vaccinate 500,000 civilian health-care workers and emergency response teams against smallpox was begun.
Recent Videos
Related Content
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024Article
The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.
